Given the controversy surrounding the aetiology of cat scratch disease and the association of both Bartonella henselae and B. quintana with bacillary angiomatosis, a method for the direct detection in clinical samples of 16s rRNA from the Proteobacteria alpha subgroup was developed. The primary structure of amplified 16s rDNA was determined by cloning and sequencing. Three sequences were identified: one corresponded exactly to GenBank accession number M73229 (B. henselae); the second was related to, but distinct from, GenBank accession number 211684 (referred to as 'B. henselae variant'); and a third sequence was identical with GenBank accession number M73228 (B. quintana). No sequence corresponding to Aflpia spp. was found. To speed identification and reduce the cost of analysis, a nested amplification method for B. henselae and B. quintana was devised. These techniques were applied to DNA extracted from 30 unfixed lymph node biopsies, two liver biopsies and 36 node pus samples from patients with suspected cat scratch disease, and from 17 skin biopsies from AIDS patients with suspected bacillary angiomatosis. B. henselae or B. henselae variant sequences were found in 42 (62%) of 68 samples from suspected cat scratch disease. B. quintana was not associated with cat scratch disease, but a B. quintana sequence was found in seven (41%) of 17 samples from suspected bacillary angiomatosis patients. B. henselae 16s rDNA sequences were not found in bacillary angiomatosis specimens.
Introduction
Cat scratch disease (CSD) has been known for 45 years as an infectious disease transmitted to man by cats [l] . This relatively common cause of subacute regional lymphadenopathy is diagnosed currently on the basis of three of four criteria: contact with or scratch from a cat; negative conventional bacteriological results; positive skin test with heated purulent lymph node material from a patient with CSD; gramnegative bacilli visualised by Warthin Starry silver stain in lymph node tissues [2, 3] . The precise identification of the aetiological agent has been the source of controversy. Various bacteria have been successively incriminated [4, 5] , including Afipia felis and Rochalimaea henselae [6, 7] , but at the present time R. henselae seems to be the only causal agent of CSD in the USA [8, 9] .
The AIDS epidemic has allowed the emergence of infections that were previously unknown or rare. Among these infections is bacillary epitheloid angiomatosis (BA). This debilitating systemic disease is characterised by vascular lesions that are generally cutaneous and less frequently hepatic, splenic, pulmonary or cerebral [ 10, 1 11. Molecular methods have implicated R. quintana in this disease, a bacterium described long ago as causing trench fever [9-121. Both R. henselae and R. quintana have been isolated from bacillary angiomatosis in the USA [3-7, 13, 141.
Isolation of the causative bacterium from CSD and BA is tedious and often fails. Molecular methods now allow the detection of non-cultivable bacteria, based on 16s rRNA sequence comparisons [15] . Rapidly expanding international data bases now contain c. 3500 bacterial 16s rRNA sequences. Use of these sequences has allowed the detection and identification of bacteria without culture [16] .
The CSD and BA agents belong to the alpha subgroup Unfixed lymph node biopsy specimens ( n = 30) and lymph node aspirates (n = 36) were from patients diagnosed clinically as having CSD. Liver biopsies (n = 2) were from hepatic peliosis. Skin biopsies (n = 17) were from AIDS patients with suspected BA. All samples were incubated in a water bath at 65°C for 30 min to inactivate human immunodeficiency virus. In this work, no attempt was made to isolate the aetiological agents, but the rapidly expanding 16s rRNA sequence databases were used to identify the agents associated with CSD and BA in France. Taking into account the potential diversity of agents causing DNA extraction CSD and BA, primers were designed to amplify selectively, from clinical samples, 16s rRNA genes (16s rDNA) from all members of the alpha subgroup of Proteobacteria. The primary structure of the amplified 16s rDNA was determined by cloning and sequencing. Comparison of the 16s rDNA sequences obtained with the databases allowed the identification of any alpha-Proteobacteria (Bartonella spp., Afipia spp. or others). To speed identification, a nested amplification method was devised for B. henselae and B. quintana.
DNA was extracted from cultures or clinical samples with a modification of a procedure described previously for rickettsiae [22] . Following incubation overnight at 55°C in lysis buffer (0.5 M Tris, pH 9, 20mM EDTA, 10mM NaC1, SDS 1% w/v and proteinase K, Sigma, 1 mg/ml), the DNA was purified by phenol-chloroform extraction and ethanol precipitation [23] . A negative control (all the reagents without DNA sample) was included in each experiment to ensure that none of the extraction buffers and reagents was contaminated with target DNA.
16s rDNA amplification
Materials and methods
Reaction mixtures were prepared in a laminar flow
Bacterial strains
The strains of bacteria used to evaluate the specificity of the PCR tests or as positive controls are listed in hood which was irradiated subsequently by UV light. A separate set of pipettes and aerosol-guarded tips were used exclusively for preparation of reaction mixtures to avoid contamination [24] . The areas used for PCR preparation were isolated from electrophoresis units.
PCR amplification was performed with a DNA Thermal Cycler Model 480 (Perkin Elmer). A blank control lacking template DNA was included in each experiment and yielded no amplification product, demonstrating that DNA contamination was not present. DNA extracted from A . felis was used as a positive control. If no specific amplification product was detected and when a blur was seen on the agarose gel, the PCR was repeated with a 10-and 100-fold diluted sample to remove inhibitory compounds in the sample.
Two oligonucleotide primers, Alpha and r-Alpha (Table 2) [25], were used for 16s rDNA amplification before sequencing. These primers were selected on the basis of sequence conservation in the alpha subgroup of Proteobacteria after comparison of 87 Proteobacteria alpha subgroup 16s rDNA sequences from GenBank [26] . Bio-Tag polymerase (Bioprobe, Montreuil-sous-bois, France) was used in amplification reactions consisting of 5 min at 94°C; 35 cycles of 94°C for 1 min, 65°C for 1 min and 72°C for 1 min; and a final elongation step at 72°C for 5 min.
Two other primers, A-proteo and r-Alpha-sh (Table 2) , were also used in initial sequence experiments. Primer A-proteo was selected on the basis of sequence conservation in the Proteobacteria phylum. Primer rAlpha-sh is shorter than r-Alpha in order to have an annealing temperature compatible with that of primer A-proteo. Hi-Tag polymerase (Bioprobe) was used in amplification reactions identical to those above except that the primer hybridisation step was at 62°C for 1 min. 
Nested PCR and RFLP analysis
Proteobacteria alpha subgroup 16s rDNA was amplified with Hi-Tag polymerase and primers A-proteo and r-Alpha-sh ( Table 2 ). The strains listed in Table 1 were used as positive or negative controls. Two samples known to contain different B. henselae 16s rDNA sequences were also included as controls.
To detect Bartonella spp., PCR was performed with two oligonucleotide primers, Bart and r-BH (Table 2) . Primer Bart (position 95) was selected after examination of 87 Proteobacteria alpha subgroup 16s rDNA sequences for sequence signature of the genus Bartonella. The target sequence of this primer was identical for B. henselae, B. quintana, B. vinsonii, B. doshiae and B. grahamii. The corresponding sequence of B. elizabethae differed from the other Bartonella sequences at six positions (mostly at the 5' end of the oligonucleotide). Primer r-BH (position 1092) was deduced from the 16s rDNA signature sequence of B. henselae [ 141. Nested PCR was performed with primer Bart, specific for genus Bartonella 16s rDNA, and reverse primer r-BH, specific for B. henselae 16s rDNA, used at low stringency (65°C). Depending on the amount of alpha 16s rDNA amplified product, the nested PCR was performed with 1 pl of a 1 in 10 or 1 in 100 dilution of PCR product, and one cycle of predenaturation at 94°C for 5 min, followed by 35 cycles comprising denaturation at 94°C for 1 min, annealing at 65°C for 1 min, and extension at 72°C for 1 min. The amplicons were then allowed to extend at 72°C for 5 min. Amplified products were detected by electrophoresis as described above. (Fig. 1) .
Nested PCRs at low stringency (65°C) with primers Bart and r-RH yielded a 990-bp amplicon that was specific for the genus Bartonella. Fig. 2A [33] , heterogeneity of 16s rRNA copies within a strain [34] , or sequencing errors. It is accepted that strains with 16s rRNA homology values of < 97.5% are unlikely to belong to a single species [35] , but identical or nearly identical sequences are not proof of identity at the species level [36] . The best solution to this problem would be to grow and isolate bacteria and then either perform quantitative DNA-DNA hybridisation or an identification test that correlates with DNA group assignment. However, when bacteria are non-cultivable, or cultivable only at very low efficiency, amplification and sequencing of rDNA may be the method of choice for use in a laboratory which is not specialised in the study of a particular bacterial group.
To reduce the costs and labour associated with DNA sequencing, a set of nested PCR tests was developed. Taking into account the potential diversity of agents causing CSD and BA, the PCR first amplifies a sequence specific for the Proteobacteia alpha subgroup. The second PCR indicates whether the amplified fragment corresponds to the genus Bartonella. Any amplified fragment not corresponding to Bartonella should be sequenced. The Bartonellaspecific PCR test can be used for species identification by repeating the PCR at a higher (72°C) temperature (for B. henselae) or by HincII digestion of the PCR products (for B. quintana). No additional hybridisation steps are required for identification of these two species.
In total, 62% of samples from suspected cases of CSD gave positive results in the nested PCR specific for B. henselae. This is lower than the figure of 84% reported by Anderson et al. [8] , but similar to the figure of 60% reported by Bergmans et al. [30] . The difference may be related to the type of cases selected. Anderson et al. [8] detected B. henselae DNA in 86% of patients with B. henselae antibody titres of 2 64. The study by Bergmans et al. [30] , and the present study, reported results from a group of patients who were only suspected as having CSD (lymphadenopathy, cat contact, absence of other obvious diagnosis). In this study, Bartonella antibody titres were known in only 19 cases, and only nine of these 19 patients had positive serology. Of these nine positive patients, eight (88%) yielded a positive PCR test for Bartonella.
The major problem in clinical microbiology is to associate a micro-organism with a disease. Although A . felis was originally associated with CSD [6], the present study found that B. henselae sequences were associated with CSD when the Proteobacteria alpha subgroup amplification was positive. No Afipia sequences were found. In the USA, both B. henselae and B. quintana have been associated with BA [7, 13, 141. It was surprising to find only the B. quintana sequence in skin biopsies when the Proteobacteria alpha subgroup amplification was positive.
More specimens need to be studied to verify whether the aetiological agent of BA is limited to B. quintana in Europe. The nested PCR described in this paper is now used routinely in our Institute for this purpose.
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